eCommons@AKU
Department of Biological & Biomedical Sciences

Medical College, Pakistan

January 2012

Ethnopharmacological studies on chrozophora
prostrata in perspective of its folkloric reputation as
purgative
Usman Arshad
Bahauddin Zakariya University

Khalid Hussain Janbaz
Bahauddin Zakariya University

Samra Bashir
Aga Khan University

Najeeb-ur- Rehman
Aga Khan University

Hassan Mehmood
Aga Khan University, hassan.mehmood@aku.edu
See next page for additional authors

Follow this and additional works at: https://ecommons.aku.edu/pakistan_fhs_mc_bbs
Recommended Citation
Arshad, U., Janbaz, K., Bashir, S., Rehman, N., Mehmood, H., Gilani, A. (2012). Ethnopharmacological studies on chrozophora
prostrata in perspective of its folkloric reputation as purgative. Bangladesh Journal of Pharmacology, 7(4), 243-248.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_bbs/331

Authors

Usman Arshad, Khalid Hussain Janbaz, Samra Bashir, Najeeb-ur- Rehman, Hassan Mehmood, and Anwar-ulHassan Gilani

This article is available at eCommons@AKU: https://ecommons.aku.edu/pakistan_fhs_mc_bbs/331

A Journal of the Bangladesh Pharmacological Society (BDPS)
Bangladesh J Pharmacol 2012; 7: 243-248
Journal homepage: www.banglajol.info; www.bdjpharmacol.com
Abstracted/indexed in Academic Search Complete, Agroforestry Abstracts, Asia Journals Online, Bangladesh Journals Online, Biological Abstracts,
BIOSIS Previews, CAB Abstracts, Current Abstracts, Directory of Open Access Journals, EMBASE/Excerpta Medica, Google Scholar, HINARI (WHO),
International Pharmaceutical Abstracts, Open J-gate, Science Citation Index Expanded, SCOPUS and Social Sciences Citation Index
ISSN: 1991-007X (Print); 1991-0088 (Online); DOI: 10.3329/bjp.v7i4.12351

Ethnopharmacological studies on Chrozophora prostrata in
perspective of its folkloric reputation as purgative
Usman Arshad1,2, Khalid Hussain Janbaz 1, Samra Bashir3, Najeeb-ur-Rehman3, Malik
Hassan Mehmood3 and Anwar-ul-Hassan Gilani3
1

Faculty of Pharmacy, Bahauddin Zakariya University, Multan; 2Department of Pharmacy, COMSATS Institute of
Information Technology, Abbottabad; 3Natural Product Research Division, Department of Biological and Biomedical
Sciences, Aga Khan University Medical College, Karachi 74 800, Pakistan.

Article Info

Abstract

Received:
24 October 2012
Accepted:
25 October 2012
Available Online:
26 October 2012
Keywords:
Cholinergic
Chrozophora prostrata
K+ channel opener
Purgative
Spasmolytic

This study was undertaken to validate the medicinal use of Chrozophora
prostrata in constipation. The crude extract of C prostrata produced laxative
effect in mice at 100 and 300 mg/kg, similar to carbachol and castor oil. In
spontaneously contracting rabbit jejunum tissues, C. prostrata (0.01-3 mg/mL)
exhibited atropine-sensitive spasmogenic effect, which was reproducible in
guinea-pig ileum. Interestingly, at high concentrations, C. prostrata showed
concentration-dependent inhibitory effect on rabbit jejunum, suggesting the
presence of accompanied spasmolytic activity. When tested on induced
contractions, C. prostrata completely relaxed low K+-induced contraction, while
partially inhibited high K+, similar to cromakalim. Tetraethylammonium
pretreatment abolished the relaxant effect of C. prostrata on low K+-induced
contractions while glibenclamide caused partial inhibition, suggesting the
involvement of some non-specific and ATP-dependent K+ channels. These
data show that C. prostrata possesses laxative effect at low doses mediated
through cholinergic action followed by the spasmolytic activity at high doses
mediated possibly through K+ channel activation.
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Introduction
Chrozophora prostrate (C. prostrata), Dalz. (Family;
Euphorbiaceae) is locally known as Nilkanthi (Caius,
1986). It grows in water logged areas and river banks as
well as the dried areas of Pakistan (Caius, 1986; Nasir
and Ali, 1986). It is known to be rich in
leucoanthocyanidin, flavonoid and coumarin
derivatives. Two xanthone glycosides i.e., 3,5,6,7,8pentamethoxyzanthone-1-O-rhamnosyl
(1→6)
glucopyranoside and 3,5,8-trimethoxyxanthone-1-Oglucopyranoside as well as a chromone glycoside i.e., 2acetonyl-5-methyl-7-hydroxy-6-C-glucopyranosyl
chromone-2”-O-glucopyranoside have been identified
from the roots of C. prostrata (Agrawal and Singh, 1988).

Different parts of the plant have extensively been used
in the native system of medicine to treat various kinds
of ailments. The leaves are presumed to possess
depurative properties (Evan, 2002) and the seeds are
known to possess laxative and alterative properties
(Nadkarni, 1976). Ash of the root is used to manage
cough in children (Kritkar and Basu, 1975). Decoction
made from the plant has been employed to control
leprous affections (Said, 1972). It is also regarded as
blood purifier and used for the treatment of chronic
persistent fever, syphilis, gonorrhea as well as
leucoderma (Awan, 1993).
The present study was undertaken to evaluate the
folkloric repute laxative activity of C. Prostrata to
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rationalize its medicinal use by using both the in vitro
and in vivo models.

Materials and Methods
Plant material and the extraction procedure: The dried
plant material was purchased from a local herbal store
in Multan, Pakistan and was identified by a taxonomist,
Ms Saima Shehzadi, of the Institute of Pure and
Applied Biology, Bahauddin Zakariya University,
Multan. A specimen of the plant has been deposited at
Herbarium at the Department of Biological and
Biomedical Sciences Aga Khan University, Karachi,
against voucher number Cp. A. 06-08-119. The herbal
material was rendered free of any adulterant through
manual picking and was ground to a coarse powder by
an electrical grinder. Approximately 1 kg coarsely
powdered plant material was soaked in the 80%
aqueous-ethanol for one week with occasional shaking.
It was passed through a double layer of muslin cloth
and the obtained fluid was subsequently filtered
through a Whatman grade 1 filter paper. The collected
filtrate was concentrated on rotary evaporator (R-210,
BUCHI, Switzerland) under reduced pressure at 37ºC to
a thick, semi- solid mass, i.e., the crude ethanolic extract
with the approximate yield of 8.3%.
Animals: Rabbits and mice of local breed and either sex
were used in the experiments and were kept at the
animal house of Aga Khan University, Karachi, at 2325°C. Animals were provided with standard diet and
tap water ad libitum but were subjected to 24 hours
starvation prior to the experiments. Rabbits were
sacrificed by a blow on the back of head for the in vitro
experiments on gut tissues, while mice were used for
the in vivo laxative study and acute toxicity testing. The
animals were used in line with the guidelines of the
Institute of Laboratory Animal Resources, Commission
on Life Sciences, National Research Council (NRC,
1996).
Chemicals: The following chemicals were obtained from
the sources specified: Acetylcholine chloride, atropine
sulfate, potassium chloride, carbachol, cromakalim,
glibenclamide, and tetra-ethyl ammonium chloride
(TEA) from Sigma Chemicals Co. St Louis, MO, USA.
Calcium chloride, glucose, magnesium chloride,
sodium bicarbonate, sodium dihydrogen phosphate,
hydrochloric acid, ethanol, acetic anhydride, ether,
benzene and chloroform from Merck, Darmstadt,
Germany, while sodium chloride, sodium hydroxide
and ammonium hydroxide from BDH Laboratory
supplies, Poole, England. All chemicals used in these
experiments were of the highest purity and research
grade. Stock solutions of all chemicals were prepared in
normal saline, except cromakalim and glibenclamide
which were dissolved in 10% DMSO (Di-methyl
sulfoxide) and the volume made up by normal saline.

The vehicle used for solubilization of drugs had no
effect on tissue contractility in the control experiments.
The stock solutions and their dilutions were made fresh
on the day of experiment.
In vivo experiments: Mice were used as the in vivo animal
models for the evaluation of laxative activity in test
materials in comparison to castor oil and carbachol as
standard diarrhea inducers. Mice were deprived of food
for 24 hours prior to the experiment but had free access
to water. Twenty five animals were divided into five
groups, each containing five mice. Each mouse was
kept in a separate cage over a blotting sheet for
convenience in fecal counting. Group1st animals,
considered as the negative control, were treated orally
with normal saline (10 mL/kg), group 2nd and 3rd, the
positive controls, with castor oil (10 mL/kg) and
carbachol (2 mg/kg), respectively, while the animal of
group 4th and group 5th, labeled as the test groups,
received oral doses of 100 and 300 mg/Kg of C. prostrata
respectively. Total number of feces was counted for
each mouse separately and calculated the average
number of feces for each group.
In vitro experiments: The effect of C. prostrata on gut
motility was studied in isolated rabbit jejunum and
guinea-pig ileum preparations as described previously
(Shah et al., 2011). Approximately 2 cm long segments
of jejunum or ileum were suspended in tissue baths
containing Tyrode’s solution maintained at 37°C and
aerated with carbogen (95% O2 and 5% CO2). Intestinal
responses were recorded isotonically using Bioscience
transducers attached to an Oscillograph and Powerlab
Data Acquisition System (AD Instruments, Sydney,
Australia) linked to a computer installed with Labchart
software (version 6). The tissues were allowed to
equilibrate for 30 min prior to addition of any chemical
substance. The tissues were stabilized following
repeated exposure to acetylcholine (0.3 μM) after
washing with the Tyrode’s solution until the submaximal responses of uniform amplitude were
obtained. The observed modulation of spontaneous
rhythmic contractions was used to test spasmolytic or
spasmogenic activity in spontaneously contracting
isolated rabbit jejunum preparation, whereas, induction
of contraction with test or control drugs above that of
the basal tone was used to measure spasmogenic
activity in guinea-pig ileum.
Acute toxicity testing: Mice were used for assessment of
the acute toxicity. The animals were fasted 24 hours
prior to experimentation but allowed free access to
water. Twenty mice were divided into four groups each
containing five animals. Group 1 was given normal
saline (0.9% sodium chloride) orally and considered as
the control group. Group 2, 3 and 4 were orally
administered with 3, 5 and 7 g/Kg of C. prostrata,
respectively. All the groups were observed for 24 hours
for possible lethargy and mortality.
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Statistical analysis: The data are expressed as the mean ±
standard error of the mean (S.E.M.) and the median
effective concentrations (EC50 values) with 95%
confidence intervals (CI). The statistical test applied is
the Student’s t-test and p<0.05 is considered as
significantly different.
Results
Oral administration of castor oil (10 mL/kg) and
carbachol (2 mg/kg) to mice resulted in significant
laxative effect with mean fecal count of 10.60 ± 2.04 and
10.20 ± 0.58, respectively, as compared to 5.2 ± 1.48 with
saline. In the test groups, treatment with 100 and 300
mg/kg C. prostrata exhibited dose-dependent laxative
effect with respective mean fecal count of 8.20 ± 1.02
and 13.40 ± 2.54 (Figure 1).
Application of C. prostrata on spontaneously contracting
rabbit jejunum exhibited biphasic response i.e., initial
concentration-dependant (0.01-0.3 mg/mL) excitation
followed by the concentration-dependant inhibition of
the spontaneous contractions (1-3 mg/mL). The
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spasmogenic effect of C. prostrata was suppressed by
pretreatment of the tissues with 0.1 μM atropine (Figure
2a). C. prostrata caused relaxation of low K+ (25 mM)induced contractions with EC50 value of 0.22 mg/mL
(0.16-0.31, 95% CI) whereas, it caused partial relaxation
of high K+ (80 mM)-induced contractions, similar to
cromakalim (Figure 2a and b). When applied on guinea
-pig ileum, C. prostrata caused contractions in a
concentration-dependent manner. The respective
contractions at 0.3, 1, 3 and 10 mg/mL were recorded as
7.67 ± 1.45, 15.00 ± 2.89, 34.67 ± 2.91 and 54.67% ± 4.67
of the ACh-induced maximum response (Figure 3). Preincubation of the tissue with atropine 0.1 µM abolished
the spasmogenic effect of C. prostrata, like that of
acetylcholine.
The inhibitory effect of C. prostrata was blocked in the
tissues pretreated with TEA (10 mM) while partially
reversed in the glibenclamide (30 μM) pretreated
preparations. The inhibitory effect of cromakalim on
low K+-induced contractions was completely inhibited
in the tissue pretreated with glibenclamide (Figure 4a
and b).

Figure 1: Comparative laxative effect of 100 mg/Kg and 300 mg/kg crude extract of C. prostrata , castor oil (10 ) and carbachol (2
mg/Kg) against normal saline (10 mL/kg) in healthy mice. *p < 0.05, **p<0.01 vs. Saline group.
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Figure 2: Effect of crude extract of C. prostrata on spontaneous, atropine (0.1 µM) incubated spontaneous, K + (80 mM) and K+ (25
mM)-induced contractions (a) and that of cromakalim on spontaneous, K + (80 mM) and K+ (25 mM) induced contractions (b) in
isolated rabbit jejunum preparations (values expressed are mean ± S.E.M. for n = 5).

Figure 3: Concentration-dependent spasmogenic effect of crude
extract of C. prostrata in the absence and presence of atropine
(0.1 µM) in isolated guinea-pig ileum. The responses are given
as % of acetylcholine (10 µM) induced maximum contraction
(ACh Max.). The values are shown as mean ± SEM, n = 4.

The oral dose of C. prostrata as high as 7 mg/ Kg, did
not produce lethality among the treated groups of mice.

Discussion
C. prostrata was subjected to pharmacological
investigation in order to validate its folkloric repute in

constipation (Nadkarni, 1976). When studied for its
laxative effect in mice, C. prostrata enhanced fecal
production similar to CCh. To study the possible mode
of action of its laxative activity, the aqueous ethanolic
plant extract was tested on spontaneously contracting
rabbit jejunum preparations, where it produced
atropine-sensitive spasmogenic effect at lower
concentrations, indicating possible presence of gut
stimulatory component(s). The spasmogenic effect of C.
prostrata was further studied on guinea-pig ileum, a
quiescent preparation considered useful for this
purpose (Bashir et al., 2006). The plant extract produced
contractions in ileum preparations which were also
blocked in the presence of atropine, thus confirming the
presence of spasmogenic effect in C. prostrata mediated
possibly through stimulation of cholinergic receptors,
similar to ACh, which is known to have excitatory
action on gut segments (Brown and Taylor, 2006). The
spasmodic effect observed at low concentrations in
rabbit jejunum was moderate when compared with
ACh-induced maximum contractions.
Interestingly at higher concentrations, C. prostrata failed
to produce spasmogenic effect and showed dosedependent spasmolytic activity which is perhaps meant
by nature to offset the excessive stimulation of gut
motility which could be harmful through causing
abdominal cramps, as seen with chemical drugs used as
laxative (Pasricha, 2008). The observed spasmolytic
effect of the plant extract when investigated for possible
mechanisms, it showed selective inhibition of low K+induced contractions while a weak inhibitory influence
was observed against high K+. As the plant extract was
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Figure 4: Effect of crude extract of C. prostrata (a) and cromakalim (b) against K+ (25 mM)-induced contractions in the absence of
any K+ channel antagonist and in the presence of tetraethylammonium chloride (TEA; 10 mM) and glibenclamide (GB; 30 μM) in
isolated rabbit jejunum preparations (values expressed are mean ± S.E.M. for n = 4).

capable to cause complete relaxation of low K+-induced
spastic contractions, hence, it can be speculated that
some of the plant components may possibly exert their
effect through opening of K+ channels (Hamilton et al.,
1986; Kishii et al., 1992; Khan et al., 2011). K+ channel
openers produce smooth muscle relaxation via
decreased intracellular free Ca+2 mediated by hyperpolarization of membrane through increased K+ efflux
on opening of K+ channels (Quest and Cook, 1989;
Weston and Edwards, 1992).
To know the nature of K+-channels involved in the
antispasmodic effect of the plant extract, its relaxant
effect against low K+ was reproduced in the presence of
TEA, a nonspecific K+-channel blocker (Wu et al., 2004)
and glibenclamide, an ATP-dependent K+-channel
blocker (Frank et al., 1994). TEA completely inhibited
the inhibitory effect of C. Prostrata, while glibenclamide
showed partial inhibition, showing the predominant
involvement of non-specific K+-channel activation and
the partial involvement of the specific ATP-dependent
K+-channels. On the other hand, the inhibitory effect of
cromakalim, a specific ATP-dependent K+-channel
opener (Escande et al., 1988), was completely inhibited
when studied in tissues pretreated with glibenclamide.
C. prostrata was found safe in mice up to the dose of as
high as 7 g/kg indicating that it is relatively safe for
short term use, though further chronic toxicity testing is
required to know the true safety profile.
These data indicate that C. prostrata possesses laxative
and gut stimulant properties possibly mediated
through cholinergic receptor stimulation. However, the
accompanied spasmolytic effect observed at high doses

was found mediated through non-specific and ATPsensitive K+-channel activation and was perhaps meant
by nature to offset the excessive stimulation which
could have been harmful.
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